SY-1365, a covalent, first in-class CDK7 inhibitor for cancer treatment (ChIP-Seq)
Ontology highlight
ABSTRACT: SY-1365, a covalent, first in-class CDK7 inhibitor for cancer treatment (ChIP-Seq)
PROVIDER: PRJNA497305 | ENA |
REPOSITORIES: ENA
ACCESS DATA